PT Metro Healthcare Indonesia Tbk (IDX: CARE)
Indonesia
· Delayed Price · Currency is IDR 93.00
-2.00 (-2.11%)
Sep 9, 2024, 4:00 PM WIB
CARE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 301,357 | 242,681 | 260,426 | 290,934 | 216,296 | 154,077 | Upgrade
|
| Revenue Growth (YoY) | 18.39% | -6.81% | -10.49% | 34.51% | 40.38% | 76.68% | Upgrade
|
| Cost of Revenue | 209,758 | 154,716 | 166,533 | 146,481 | 114,639 | 79,482 | Upgrade
|
| Gross Profit | 91,599 | 87,965 | 93,893 | 144,454 | 101,657 | 74,596 | Upgrade
|
| Selling, General & Admin | 124,269 | 115,939 | 145,618 | 120,302 | 111,011 | 64,439 | Upgrade
|
| Other Operating Expenses | 7,048 | 7,782 | 8,663 | 8,748 | 3,569 | 1,482 | Upgrade
|
| Operating Expenses | 131,700 | 124,104 | 154,484 | 130,356 | 117,174 | 65,921 | Upgrade
|
| Operating Income | -40,101 | -36,139 | -60,591 | 14,098 | -15,517 | 8,674 | Upgrade
|
| Interest Expense | -76,598 | -75,775 | -89,333 | -25,432 | -11,306 | -19,249 | Upgrade
|
| Interest & Investment Income | 5,867 | 6,623 | 31,785 | 15,782 | 40,428 | 4,663 | Upgrade
|
| Other Non Operating Income (Expenses) | 156.38 | -904.24 | -844.92 | -694.16 | 187.68 | -2,141 | Upgrade
|
| EBT Excluding Unusual Items | -110,675 | -106,195 | -118,984 | 3,754 | 13,793 | -8,053 | Upgrade
|
| Gain (Loss) on Sale of Assets | 72 | 72 | 25,668 | 76.36 | - | -13,472 | Upgrade
|
| Other Unusual Items | - | - | - | 2,676 | - | - | Upgrade
|
| Pretax Income | -110,603 | -106,123 | -93,316 | 6,507 | 13,793 | -21,524 | Upgrade
|
| Income Tax Expense | 5,271 | 4,566 | 288.46 | 332.91 | -375.14 | 2,762 | Upgrade
|
| Earnings From Continuing Operations | -115,874 | -110,689 | -93,604 | 6,174 | 14,168 | -24,286 | Upgrade
|
| Minority Interest in Earnings | -277.01 | -230.93 | 60.53 | -74.43 | 144.89 | 80.93 | Upgrade
|
| Net Income | -116,151 | -110,920 | -93,544 | 6,099 | 14,313 | -24,205 | Upgrade
|
| Net Income to Common | -116,151 | -110,920 | -93,544 | 6,099 | 14,313 | -24,205 | Upgrade
|
| Net Income Growth | - | - | - | -57.39% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 33,250 | 33,250 | 33,250 | 33,250 | 28,250 | 7,752 | Upgrade
|
| Shares Outstanding (Diluted) | 33,250 | 33,250 | 33,250 | 33,250 | 28,250 | 7,752 | Upgrade
|
| Shares Change (YoY) | - | - | - | 17.70% | 264.44% | 309966.67% | Upgrade
|
| EPS (Basic) | -3.49 | -3.34 | -2.81 | 0.18 | 0.51 | -3.12 | Upgrade
|
| EPS (Diluted) | -3.49 | -3.34 | -2.81 | 0.18 | 0.51 | -3.12 | Upgrade
|
| EPS Growth | - | - | - | -63.79% | - | - | Upgrade
|
| Free Cash Flow | -124,274 | -95,595 | -339,291 | -263,276 | -471,965 | -386,287 | Upgrade
|
| Free Cash Flow Per Share | -3.74 | -2.88 | -10.20 | -7.92 | -16.71 | -49.83 | Upgrade
|
| Gross Margin | 30.40% | 36.25% | 36.05% | 49.65% | 47.00% | 48.41% | Upgrade
|
| Operating Margin | -13.31% | -14.89% | -23.27% | 4.85% | -7.17% | 5.63% | Upgrade
|
| Profit Margin | -38.54% | -45.71% | -35.92% | 2.10% | 6.62% | -15.71% | Upgrade
|
| Free Cash Flow Margin | -41.24% | -39.39% | -130.28% | -90.49% | -218.20% | -250.71% | Upgrade
|
| EBITDA | -26,609 | -14,554 | -37,714 | 31,395 | -3,398 | 16,785 | Upgrade
|
| EBITDA Margin | -8.83% | -6.00% | -14.48% | 10.79% | -1.57% | 10.89% | Upgrade
|
| D&A For EBITDA | 13,492 | 21,585 | 22,878 | 17,297 | 12,119 | 8,111 | Upgrade
|
| EBIT | -40,101 | -36,139 | -60,591 | 14,098 | -15,517 | 8,674 | Upgrade
|
| EBIT Margin | -13.31% | -14.89% | -23.27% | 4.85% | -7.17% | 5.63% | Upgrade
|
| Effective Tax Rate | - | - | - | 5.12% | - | - | Upgrade
|
| Advertising Expenses | - | 332.36 | 621.1 | 204.18 | - | 905.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.